Share-based Payment Arrangement, Expense of NovaBay Pharmaceuticals, Inc. from 30 Jun 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NovaBay Pharmaceuticals, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2012 to 31 Dec 2024.
  • NovaBay Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $11,000, a 88% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $148,000, a 49% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $148,000, a 49% decline from 2023.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $291,000, a 32% increase from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $220,000, a 76% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NovaBay Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $148,000 $11,000 -$79,000 -88% 01 Oct 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
Q3 2024 $227,000 $22,000 -$40,000 -65% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $267,000 $55,000 -$9,000 -14% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $276,000 $60,000 -$15,000 -20% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $291,000 $90,000 $0 0% 01 Oct 2023 31 Dec 2023 10-K 02 Apr 2025 2024 FY
Q3 2023 $291,000 $62,000 +$270,000 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $21,000 $64,000 -$90,000 -58% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $111,000 $75,000 -$109,000 -59% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $220,000 $90,000 -$27,000 -23% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $247,000 $208,000 -$432,000 -193% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $679,000 $154,000 -$142,000 -48% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $821,000 $184,000 -$112,000 -38% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $933,000 $117,000 -$56,000 -32% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $989,000 $224,000 +$48,000 +27% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $941,000 $296,000 +$170,000 +135% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $771,000 $296,000 +$239,000 +419% 01 Jan 2021 31 Mar 2021 10-Q 11 Aug 2022 2022 Q2
Q4 2020 $532,000 $173,000 +$30,000 +21% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $502,000 $176,000 +$70,000 +66% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $432,000 $126,000 +$3,000 +2.4% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $429,000 $57,000 -$57,000 -50% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $486,000 $143,000 -$20,000 -12% 01 Oct 2019 31 Dec 2019 10-K 29 Mar 2022 2021 FY
Q3 2019 $506,000 $106,000 -$62,000 -37% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $568,000 $123,000 -$31,000 -20% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $599,000 $114,000 -$72,000 -39% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $671,000 $163,000 +$250,000 01 Oct 2018 31 Dec 2018 10-K 25 Mar 2021 2020 FY
Q3 2018 $421,000 $168,000 -$772,000 -82% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $1,193,000 $154,000 -$342,000 -69% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $1,535,000 $186,000 -$1,007,000 -84% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $2,542,000 $87,000 -$611,000 -117% 01 Oct 2017 31 Dec 2017 10-K 26 Mar 2020 2019 FY
Q3 2017 $3,153,000 $940,000 +$230,000 +32% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $2,923,000 $496,000 +$226,000 +84% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $2,697,000 $1,193,000 +$946,000 +383% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $1,751,000 $524,000 +$151,000 +40% 01 Oct 2016 31 Dec 2016 10-K 29 Mar 2019 2018 FY
Q3 2016 $1,600,000 $710,000 +$489,000 +221% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $1,111,000 $270,000 -$233,000 -46% 01 Apr 2016 30 Jun 2016 10-Q 10 Aug 2017 2017 Q2
Q1 2016 $1,344,000 $247,000 -$38,000 -13% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $1,382,000 $373,000 +$107,000 +40% 01 Oct 2015 31 Dec 2015 10-K 21 Mar 2018 2017 FY
Q3 2015 $1,275,000 $221,000 -$31,000 -12% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $1,306,000 $503,000 +$256,000 +104% 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $1,050,000 $285,000 +$8,000 +2.9% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q4 2014 $1,042,000 $266,000 01 Oct 2014 31 Dec 2014 10-K 23 Mar 2017 2016 FY
Q3 2014 $252,000 +$29,000 +13% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2015 Q3
Q2 2014 $247,000 -$71,000 -22% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015 2015 Q2
Q1 2014 $277,000 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
Q3 2013 $223,000 +$223,000 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 $318,000 +$304,000 +2171% 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
Q3 2012 $0 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 $14,000 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2

NovaBay Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $148,000 -$143,000 -49% 01 Jan 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
2023 $291,000 +$71,000 +32% 01 Jan 2023 31 Dec 2023 10-K 02 Apr 2025 2024 FY
2022 $220,000 -$713,000 -76% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $933,000 +$401,000 +75% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $532,000 +$46,000 +9.5% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $486,000 -$185,000 -28% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2022 2021 FY
2018 $671,000 -$1,871,000 -74% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2021 2020 FY
2017 $2,542,000 +$791,000 +45% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2020 2019 FY
2016 $1,751,000 +$369,000 +27% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2019 2018 FY
2015 $1,382,000 +$340,000 +33% 01 Jan 2015 31 Dec 2015 10-K 21 Mar 2018 2017 FY
2014 $1,042,000 +$24,000 +2.4% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2017 2016 FY
2013 $1,018,000 -$522,000 -34% 01 Jan 2013 31 Dec 2013 10-K 04 Mar 2016 2015 FY
2012 $1,540,000 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.